Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2560361367', 'doi': 'https://doi.org/10.1182/blood.v116.21.3925.3925', 'title': 'Superior Efficacy of the Novel Type II, Glycoengineered CD20 Antibody GA101vs. the Type I CD20 Antibodies Rituximab and Ofatumumab', 'display_name': 'Superior Efficacy of the Novel Type II, Glycoengineered CD20 Antibody GA101vs. the Type I CD20 Antibodies Rituximab and Ofatumumab', 'publication_year': 2010, 'publication_date': '2010-11-19', 'ids': {'openalex': 'https://openalex.org/W2560361367', 'doi': 'https://doi.org/10.1182/blood.v116.21.3925.3925', 'mag': '2560361367'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1182/blood.v116.21.3925.3925', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S200071133', 'display_name': 'Blood', 'issn_l': '0006-4971', 'issn': ['0006-4971', '1528-0020'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5006906885', 'display_name': 'Sylvia Herter', 'orcid': 'https://orcid.org/0000-0002-2446-696X'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Sylvia Herter', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057235269', 'display_name': 'Inja Waldhauer', 'orcid': 'https://orcid.org/0000-0001-8008-8660'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Inja Waldhauer', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055347785', 'display_name': 'Tina Otz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Tina Otz', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007078235', 'display_name': 'Frank Herting', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210094361', 'display_name': 'Roche Pharma AG (Germany)', 'ror': 'https://ror.org/00sh68184', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I4210094361']}], 'countries': ['DE'], 'is_corresponding': True, 'raw_author_name': 'Frank Herting', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany', 'institution_ids': ['https://openalex.org/I4210094361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103583243', 'display_name': 'Sabine M. Lang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Sabine Lang', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077770252', 'display_name': 'Valeria Nicolini', 'orcid': 'https://orcid.org/0000-0003-4306-7849'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Valeria Nicolini', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067034494', 'display_name': 'Michaela Römmele', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Michaela Römmele', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112474280', 'display_name': 'Thomas Friess', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210094361', 'display_name': 'Roche Pharma AG (Germany)', 'ror': 'https://ror.org/00sh68184', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I4210094361']}], 'countries': ['DE'], 'is_corresponding': True, 'raw_author_name': 'Thomas Friess', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany', 'institution_ids': ['https://openalex.org/I4210094361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025120043', 'display_name': 'Erwin van Puijenbroek', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Erwin Van Puijenbroek', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002292400', 'display_name': 'Marina Bacac', 'orcid': 'https://orcid.org/0000-0003-0581-9579'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Marina Bacac', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055108577', 'display_name': 'K. Michael Weidner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210094361', 'display_name': 'Roche Pharma AG (Germany)', 'ror': 'https://ror.org/00sh68184', 'country_code': 'DE', 'type': 'company', 'lineage': ['https://openalex.org/I118019719', 'https://openalex.org/I4210094361']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'K. Michael Weidner', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Diagnostics GmbH, Penzberg, Germany', 'institution_ids': ['https://openalex.org/I4210094361']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011262366', 'display_name': 'Christian Gerdes', 'orcid': 'https://orcid.org/0000-0001-7658-109X'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': True, 'raw_author_name': 'Christian Gerdes', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040318787', 'display_name': 'Pablo Umaña', 'orcid': 'https://orcid.org/0000-0001-8206-2771'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Pablo Umana', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5067162282', 'display_name': 'Christian Klein', 'orcid': 'https://orcid.org/0000-0001-7594-7280'}, 'institutions': [{'id': 'https://openalex.org/I118019719', 'display_name': 'Roche (Switzerland)', 'ror': 'https://ror.org/00by1q217', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I118019719']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Christian Klein', 'raw_affiliation_strings': ['Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,'], 'affiliations': [{'raw_affiliation_string': 'Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland,', 'institution_ids': ['https://openalex.org/I118019719']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': ['https://openalex.org/A5006906885', 'https://openalex.org/A5057235269', 'https://openalex.org/A5055347785', 'https://openalex.org/A5007078235', 'https://openalex.org/A5103583243', 'https://openalex.org/A5077770252', 'https://openalex.org/A5067034494', 'https://openalex.org/A5112474280', 'https://openalex.org/A5025120043', 'https://openalex.org/A5002292400', 'https://openalex.org/A5011262366'], 'corresponding_institution_ids': ['https://openalex.org/I118019719', 'https://openalex.org/I118019719', 'https://openalex.org/I118019719', 'https://openalex.org/I4210094361', 'https://openalex.org/I118019719', 'https://openalex.org/I118019719', 'https://openalex.org/I118019719', 'https://openalex.org/I4210094361', 'https://openalex.org/I118019719', 'https://openalex.org/I118019719', 'https://openalex.org/I118019719'], 'apc_list': {'value': 5000, 'currency': 'USD', 'value_usd': 5000, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.185, 'has_fulltext': False, 'cited_by_count': 8, 'citation_normalized_percentile': {'value': 0.594981, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 84}, 'biblio': {'volume': '116', 'issue': '21', 'first_page': '3925', 'last_page': '3925'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ofatumumab', 'display_name': 'Ofatumumab', 'score': 0.9311466}, {'id': 'https://openalex.org/keywords/complement-dependent-cytotoxicity', 'display_name': 'Complement-dependent cytotoxicity', 'score': 0.59349954}], 'concepts': [{'id': 'https://openalex.org/C2778714382', 'wikidata': 'https://www.wikidata.org/wiki/Q410656', 'display_name': 'Ofatumumab', 'level': 4, 'score': 0.9311466}, {'id': 'https://openalex.org/C40677261', 'wikidata': 'https://www.wikidata.org/wiki/Q21418091', 'display_name': 'Antibody-dependent cell-mediated cytotoxicity', 'level': 4, 'score': 0.85053444}, {'id': 'https://openalex.org/C18031839', 'wikidata': 'https://www.wikidata.org/wiki/Q5009796', 'display_name': 'CD20', 'level': 3, 'score': 0.7489617}, {'id': 'https://openalex.org/C2780653079', 'wikidata': 'https://www.wikidata.org/wiki/Q412323', 'display_name': 'Rituximab', 'level': 3, 'score': 0.66878283}, {'id': 'https://openalex.org/C159654299', 'wikidata': 'https://www.wikidata.org/wiki/Q79460', 'display_name': 'Antibody', 'level': 2, 'score': 0.6274433}, {'id': 'https://openalex.org/C2777726029', 'wikidata': 'https://www.wikidata.org/wiki/Q21114926', 'display_name': 'Complement-dependent cytotoxicity', 'level': 5, 'score': 0.59349954}, {'id': 'https://openalex.org/C2779015954', 'wikidata': 'https://www.wikidata.org/wiki/Q420164', 'display_name': 'Alemtuzumab', 'level': 3, 'score': 0.54262304}, {'id': 'https://openalex.org/C542903549', 'wikidata': 'https://www.wikidata.org/wiki/Q422248', 'display_name': 'Monoclonal antibody', 'level': 3, 'score': 0.46433082}, {'id': 'https://openalex.org/C195616568', 'wikidata': 'https://www.wikidata.org/wiki/Q128711', 'display_name': 'Epitope', 'level': 3, 'score': 0.46216035}, {'id': 'https://openalex.org/C109316439', 'wikidata': 'https://www.wikidata.org/wiki/Q246181', 'display_name': 'Cytotoxicity', 'level': 3, 'score': 0.4236201}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.3849905}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.38020617}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.35898134}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.34519583}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.22273517}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.21963325}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.07207}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1182/blood.v116.21.3925.3925', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S200071133', 'display_name': 'Blood', 'issn_l': '0006-4971', 'issn': ['0006-4971', '1528-0020'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4382011009', 'https://openalex.org/W2739283320', 'https://openalex.org/W2162260323', 'https://openalex.org/W2132467087', 'https://openalex.org/W2086700464', 'https://openalex.org/W2084875238', 'https://openalex.org/W2079089580', 'https://openalex.org/W2064202025', 'https://openalex.org/W2045604672', 'https://openalex.org/W1982952278'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2560361367', 'counts_by_year': [{'year': 2013, 'cited_by_count': 3}, {'year': 2012, 'cited_by_count': 3}], 'updated_date': '2024-12-16T21:37:02.879452', 'created_date': '2016-12-16'}